S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
NYSE:GMRE

Global Medical REIT (GMRE) Stock Forecast, Price & News

$13.02
+0.30 (+2.36%)
(As of 05/13/2022 07:00 PM ET)
Add
Compare
Today's Range
$12.67
$13.08
50-Day Range
$12.49
$16.42
52-Week Range
$12.20
$18.51
Volume
373,500 shs
Average Volume
413,567 shs
Market Capitalization
$853.04 million
P/E Ratio
65.10
Dividend Yield
6.45%
Beta
0.9
30 days | 90 days | 365 days | Advanced Chart
Receive GMRE News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

Global Medical REIT logo

About Global Medical REIT

Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
26
Year Founded
N/A

Sales & Book Value

Annual Sales
$115.94 million
Cash Flow
$1.07 per share
Book Value
$8.82 per share

Profitability

Net Income
$17.62 million
Pretax Margin
16.03%

Debt

Price-To-Earnings

Miscellaneous

Free Float
60,539,000
Market Cap
$853.04 million
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/8 Dividend
3/24/2022
Dividend Payable
4/08/2022
Last Earnings
5/04/2022
Today
5/15/2022
Next Earnings (Estimated)
8/02/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.83 out of 5 stars

Finance Sector

220th out of 1,349 stocks

Real Estate Investment Trusts Industry

26th out of 233 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -













Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

Is Global Medical REIT a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Global Medical REIT stock.
View analyst ratings for Global Medical REIT
or view top-rated stocks.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,400,000 shares, an increase of 21.7% from the March 15th total of 1,150,000 shares. Based on an average daily trading volume, of 395,000 shares, the short-interest ratio is presently 3.5 days.
View Global Medical REIT's Short Interest
.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for Global Medical REIT
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) posted its earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a net margin of 14.17% and a trailing twelve-month return on equity of 3.02%. During the same period in the prior year, the company earned $0.24 EPS.
View Global Medical REIT's earnings history
.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Friday, March 11th. Stockholders of record on Friday, March 25th will be given a dividend of $0.21 per share on Friday, April 8th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 6.45%. The ex-dividend date is Thursday, March 24th. This is a boost from Global Medical REIT's previous quarterly dividend of $0.21.
View Global Medical REIT's dividend history
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT pays an annual dividend of $0.84 per share and currently has a dividend yield of 6.60%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Global Medical REIT has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Global Medical REIT is 420.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 81.55% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.
View Global Medical REIT's dividend history.

What price target have analysts set for GMRE?

3 equities research analysts have issued 12 month price objectives for Global Medical REIT's stock. Their forecasts range from $16.00 to $18.00. On average, they expect Global Medical REIT's stock price to reach $17.00 in the next year. This suggests a possible upside of 30.6% from the stock's current price.
View analysts' price targets for Global Medical REIT
or view top-rated stocks among Wall Street analysts.

Who are Global Medical REIT's key executives?
Global Medical REIT's management team includes the following people:
  • Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
  • Danica Holley, Chief Operating Officer
  • Robert J. Kiernan, Chief Financial Officer & Treasurer
  • Alfonzo Leon, Chief Investment Officer
  • Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting
What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Square (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.61%), BlackRock Inc. (7.21%), Aew Capital Management L P (5.23%), Prudential Financial Inc. (3.61%), Bank of New York Mellon Corp (1.89%) and Brown Advisory Inc. (1.74%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends for Global Medical REIT
.

Which institutional investors are selling Global Medical REIT stock?

GMRE stock was sold by a variety of institutional investors in the last quarter, including Mondrian Investment Partners LTD, BlackRock Inc., Russell Investments Group Ltd., Citigroup Inc., Pensionfund DSM Netherlands, Oppenheimer & Co. Inc., Northern Trust Corp, and Pensionfund Sabic.
View insider buying and selling activity for Global Medical REIT
or view top insider-selling stocks.

Which institutional investors are buying Global Medical REIT stock?

GMRE stock was purchased by a variety of institutional investors in the last quarter, including Aew Capital Management L P, State of New Jersey Common Pension Fund D, Sei Investments Co., American Century Companies Inc., Qube Research & Technologies Ltd, Vanguard Group Inc., Sound Income Strategies LLC, and Kingfisher Capital LLC. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, and Ronald Marston.
View insider buying and selling activity for Global Medical REIT
or or view top insider-buying stocks.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $13.02.

How much money does Global Medical REIT make?

Global Medical REIT has a market capitalization of $853.07 million and generates $115.94 million in revenue each year. The company earns $17.62 million in net income (profit) each year or $0.199990 on an earnings per share basis.

How many employees does Global Medical REIT have?

Global Medical REIT employs 26 workers across the globe.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is www.globalmedicalreit.com.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at (202) 524-6851 or via email at [email protected].

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.